Thanks.
As expected, many MRK shareholders sold OGN this morning.
What an opportunity for those of us who see real value in an independent company focused on women's health products.
It's global (only 22% in US), has diversified product lines and, most importantly, the management/Board team have first rate credentials.
If you lack the cash, it may be a a good idea to sell some MRK shares to buy more of this underpriced gem than you received in the spin-off.
Just an opinion. No promises, etc., etc.
Market Data 
Markets 
AI
